Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Hypoparathyroidism Treatment Market
Hypoparathyroidism Treatment Market Size
- Report ID: GMI8302
- Published Date: Feb 2024
- Report Format: PDF
Hypoparathyroidism Treatment Market Size
Hypoparathyroidism Treatment Market was valued at USD 1.3 billion in 2023 and is estimated to register a CAGR of 6.9% from 2024 to 2032. The market has witnessed significant growth over the recent years, driven by the increasing cases of hypoparathyroid disorders, rising number of thoracic surgeries and thyroid gland disorders, and increasing cases of thyroid cancer worldwide. Additionally, advancements in diagnostic technologies are enabling more accurate and timely diagnosis of hypoparathyroidism, leading to a higher number of patients seeking treatment. Further, growing awareness among healthcare professionals and patients about the importance of early detection and treatment is driving market growth by encouraging more proactive management of hypoparathyroidism.
Hypoparathyroidism is a rare endocrine disorder characterized by insufficient production or secretion of parathyroid hormone (PTH) by the parathyroid glands. These small glands are located in the neck, behind the thyroid gland, and play a crucial role in regulating calcium and phosphorus levels in the body. This imbalance disrupts various physiological processes in the body, affecting the muscles, nerves, and bones.
| Report Attribute | Details |
|---|---|
| Base Year: | 2023 |
| Hypoparathyroidism Treatment Market Size in 2023: | USD 1.3 Billion |
| Forecast Period: | 2024 – 2032 |
| Forecast Period 2024 – 2032 CAGR: | 6.9% |
| 2024 – 2032 Value Projection: | USD 2.4 Billion |
| Historical Data for: | 2018 – 2023 |
| No. of Pages: | 165 |
| Tables, Charts & Figures: | 290 |
| Segments covered: | Product Type, Route of Administration, Distribution Channel, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Hypoparathyroidism Treatment Market Scope
